Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc.verified

MIRM

Price:

$99.345

Market Cap:

$4.99B

Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.

Industry

Biotechnology

IPO Date

2019-07-18

Stock Exchange

NASDAQ

Ticker

MIRM

The PE Ratio as of June 2026 (TTM) for Mirum Pharmaceuticals, Inc. (MIRM) is -7.30

According to Mirum Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -7.30. This represents a change of -134.81% compared to the average of 20.97 of the last 4 quarters.

Mirum Pharmaceuticals, Inc. (MIRM) Historical PE Ratio (quarterly & annually)

How has MIRM PE Ratio performed in the past?

The mean historical PE Ratio of Mirum Pharmaceuticals, Inc. over the last ten years is -30.32. The current -7.30 PE Ratio has changed 2.31% with respect to the historical average. Over the past ten years (40 quarters), MIRM's PE Ratio was at its highest in in the September 2025 quarter at 366.56. The PE Ratio was at its lowest in in the September 2018 quarter at -493.22.

Quarterly (TTM)
Annual

Average

-30.32

Median

-9.06

Minimum

-169.72

Maximum

-4.27

Mirum Pharmaceuticals, Inc. (MIRM) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Mirum Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 659.54%

Maximum Annual PE Ratio = -4.27

Minimum Annual Increase = -60.20%

Minimum Annual PE Ratio = -169.72

Quarterly (TTM)
Annual
YearPE RatioChange
2025-169.72659.54%
2024-22.35202.55%
2023-7.3951.85%
2022-4.86-15.53%
2021-5.7634.88%
2020-4.27-60.20%
2019-10.73-38.73%

Mirum Pharmaceuticals, Inc. (MIRM) Average PE Ratio

How has MIRM PE Ratio performed in the past?

The current PE Ratio of Mirum Pharmaceuticals, Inc. (MIRM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-66.48

5-year avg

-42.01

10-year avg

-30.32

Mirum Pharmaceuticals, Inc. (MIRM) PE Ratio vs. Peers

How is MIRM’s PE Ratio compared to its peers?

Mirum Pharmaceuticals, Inc.’s PE Ratio is greater than Belite Bio, Inc (-61.02), less than Soleno Therapeutics, Inc. (28.75), less than Ligand Pharmaceuticals Incorporated (33.09), less than ADMA Biologics, Inc. (11.72), greater than Praxis Precision Medicines, Inc. (-23.58), less than ACADIA Pharmaceuticals Inc. (9.57), less than Dyne Therapeutics, Inc. (-6.65), greater than Travere Therapeutics, Inc. (-223.18), less than Ultragenyx Pharmaceutical Inc. (-4.02), greater than Telix Pharmaceuticals Limited (-424.33),

Build a custom stock screener for Mirum Pharmaceuticals, Inc. (MIRM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mirum Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mirum Pharmaceuticals, Inc. (MIRM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mirum Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Mirum Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for Mirum Pharmaceuticals, Inc. (MIRM)?

What is the highest PE Ratio for Mirum Pharmaceuticals, Inc. (MIRM)?

What is the 3-year average PE Ratio for Mirum Pharmaceuticals, Inc. (MIRM)?

What is the 5-year average PE Ratio for Mirum Pharmaceuticals, Inc. (MIRM)?

How does the current PE Ratio for Mirum Pharmaceuticals, Inc. (MIRM) compare to its historical average?